These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19303086)

  • 1. Re: Best practice statement on cryosurgery for the treatment of localized prostate cancer R. J. Babaian, B. Donnelly, D. Bahn, J. G. Baust, M. Dineen, D. Ellis, A. Katz, L. Pisters, D. Rukstalis, K. Shinohara and J. B. Thrasher J Urol 2008; 180: 1993-2004.
    Gans W
    J Urol; 2009 May; 181(5):2388. PubMed ID: 19303086
    [No Abstract]   [Full Text] [Related]  

  • 2. Best practice statement on cryosurgery for the treatment of localized prostate cancer.
    Babaian RJ; Donnelly B; Bahn D; Baust JG; Dineen M; Ellis D; Katz A; Pisters L; Rukstalis D; Shinohara K; Thrasher JB
    J Urol; 2008 Nov; 180(5):1993-2004. PubMed ID: 18817934
    [No Abstract]   [Full Text] [Related]  

  • 3. Cryosurgery for prostate cancer.
    Aus G
    J Urol; 2008 Nov; 180(5):1882-3. PubMed ID: 18801502
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review D. A. Kunkle, B. L. Egleston and R. G. Uzzo J Urol 2008; 179: 1227-1234.
    Raman JD; Cadeddu JA
    J Urol; 2008 Oct; 180(4):1567-8; author reply 1568. PubMed ID: 18710769
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Robotic simple prostatectomy R. Sotelo, R. Clavijo, O. Carmona, A. Garcia, E. Banda, M. Miranda and R. Fagin J Urol 2008; 179: 513-515.
    Goel MC
    J Urol; 2008 Oct; 180(4):1569-70; author reply 1570. PubMed ID: 18718613
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer. J. B. Malcolm, M. D. Fabrizio, B. B. Barone, R. W. Given, R. S. Lance, D. F. Lynch, J. W. Davis, M. E. Shaves and P. F. Schellhammer. J Urol 2010; 183: 1822-1828.
    Parker AS
    J Urol; 2011 May; 185(5):1983-4. PubMed ID: 21439591
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy I. M. Thompson, C. M. Tangen, D. P. Ankerst, C. Chi, M. S. Lucia, P. Goodman, H. Parnes and C. A. Coltman, Jr. J Urol 2008; 180: 544-547.
    Atmaca AF; Balbay MD
    J Urol; 2009 May; 181(5):2387-8. PubMed ID: 19303084
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes: W. T. Lowrance, E. B. Elkin, L. M. Jacks, D. S. Yee, T. L. Jang, V. P. Laudone, B. D. Guillonneau, P. T. Scardino and J. A. Eastham J Urol 2010; 183: 1366-1372.
    See WA
    J Urol; 2010 Oct; 184(4):1573-4; author reply 1574. PubMed ID: 20732691
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Best practice policy statement on urologic surgery antimicrobial prophylaxis. J. S. Wolf, Jr., C. J. Bennett, R. R. Dmochowski, B. K. Hollenbeck, M. S. Pearle and A. J. Schaeffer. J Urol 2008; 179: 1379-1390.
    Ordon M; Kodama R; Honey RJ
    J Urol; 2009 Aug; 182(2):799-800; author reply 800-1. PubMed ID: 19540529
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features: R. J. Cohen, B. A. Shannon, M. Phillips, R. E. Moorin, T. M. Wheeler and K. L. Garrett J Urol 2008; 179: 1762-1767.
    Mai KT; Veinot JP
    J Urol; 2008 Dec; 180(6):2714; author reply 214-5. PubMed ID: 18951578
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial I. M. Thompson, C. M. Tangen, J. Paradelo, M. S. Lucia, G. Miller, D. Troyer, E. Messing, J. Forman, J. Chin, G. Swanson, E. Canby-Hagino and E. D. Crawford J Urol 2009; 181: 956-962.
    Cheng T; Heng DY; Stewart D
    J Urol; 2009 Nov; 182(5):2531-2; discussion 2532-4. PubMed ID: 19766252
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer: M. J. Zelefsky, V. E. Reuter, Z. Fuks, P. Scardino and A. Shippy. J Urol 2008; 179: 1368-1373.
    Coquard R
    J Urol; 2008 Nov; 180(5):2258; author reply 2258. PubMed ID: 18804799
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. K. Eichler, S. Hempel, J. Wilby, L. Myers, L. M. Bachmann and J. Kleijnen, J Urol, 175: 1605-1612, 2006.
    Eskicorapci SY; Tuncay L
    J Urol; 2006 Dec; 176(6 Pt 1):2745; author reply 2745-6. PubMed ID: 17085209
    [No Abstract]   [Full Text] [Related]  

  • 14. [A preliminary clinical study of targeted cryoablation of prostate in the treatment of T3N0M0 prostate cancer].
    Guo Z; Wang HT; Xing WG; Liu F; Li Y; Yu HP
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2815-9. PubMed ID: 21162789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryosurgical ablation of the prostate--a minimally invasive treatment for cancer.
    Rogalla C
    Minim Invasive Surg Nurs; 1995; 9(1):33-9. PubMed ID: 7599683
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Percutaneous and laparoscopic cryoablation of small renal masses. D. S. Finley, S. Beck, G. Box, W. Chu, L. Deane, D. J. Vajgrt, E. M. McDougall and R. V. Clayman. J Urol 2008; 180: 492-498.
    Demirci DA; Akbulut Z; Balbay MD
    J Urol; 2009 Jun; 181(6):2827; author reply 2827-8. PubMed ID: 19375755
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: The 20-core prostate biopsy protocol--a new gold standard?: V. Ravery, S. Dominique, X. Panhard, M. Toublanc, L. Boccon-Gibod and L. Boccon-Gibod. J Urol 2008; 179: 504-507.
    Serefoglu EC; Ozdemir AT; Balbay MD
    J Urol; 2008 Nov; 180(5):2256-7. PubMed ID: 18804806
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Smaller prostate size predicts high grade prostate cancer at final pathology. M. R. Newton, S. Phillips, S. S. Chang, P. E. Clark, M. S. Cookson, R. Davis, J. H. Fowke, S. D. Herrell, R. Baumgartner, R. Chan, V. Mishra, J. D. Blume, J. A. Smith, Jr. and D. A. Barocas. J Urol 2010; 184: 930-937.
    Calışkan S
    J Urol; 2011 Apr; 185(4):1537-8; author reply 1538. PubMed ID: 21349547
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Validation of the Partin nomogram for prostate cancer in a national sample: J. B. Yu, D. V. Makarov, R. Sharma, R. E. Peschel, A. W. Partin and C. P. Gross J Urol 2010; 183: 105-111.
    Ozcan MF; Akbulut Z; Canda AE; Kilic M; Duran E; Balbay MD
    J Urol; 2010 Oct; 184(4):1571-2; author reply 1572-3. PubMed ID: 20732697
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer. S. T. dos Reis, J. Pontes, Jr., F. E. Villanova, P. M. D. Borra, A. A. Antunes, M. F. Dall'oglio, M. Srougi and K. R. M. Leite. J Urol 2009; 181: 2320-2325.
    Ahirwar DK; Mittal RD
    J Urol; 2010 Mar; 183(3):1258. PubMed ID: 20097381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.